medRxivGenetic & Genomic MedicinePreprint
Investigating Uptake and Impact of Genetic and Genomic Evaluation Following a Perinatal Demise
Kara MossleriD, Etta D'Orazio, Katherine Hall, Kathryn OsanniD, Virginia E. KimonisiD, Fabiola Quintero‐RiveraiD
Abstract
ObjectiveThe decline of the perinatal demise rate is slowing and demises are often unexplained. Significant research has been done regarding diagnostic yield and genetic causes of demise, but little is known about how Geneticist involvement impacts outcomes. The goal of the study was to evaluate post-mortem genetic testing practices and effects of the geneticists involvement. MethodsRetrospective data from 111 perinatal demise cases was examined, including rates of prenatal genetic counseling, post-delivery genetics consult, genetic testing, and autopsy investigation. ResultsIn this cohort 54% received genetic testing and 25% received a genetics consultation. When compared to those without, cases with genetic specialist involvement were associated with significant increases in testing uptake (p=0.007), diagnostic yield (p<0.001), and patient education (p<0.001). Second trimester stillbirths and those with fewer ultrasound (US) abnormalities were less likely to receive genetic testing (both p values <0.001) and consults (p<0.001, p=0.020). ConclusionAlthough ascertainment bias cannot be ruled out, this data demonstrates that geneticist involvement correlates with a higher rate of testing, greater diagnostic yield, and more thorough counseling. These findings underscore the importance of integrating genetics providers into perinatal postmortem healthcare teams. What is already known about this topic?- Causes of perinatal demise often are undiagnosed, but genetic and congenital anomalies are common. - ACOG recommends genetic testing for all perinatal demises What does this study add?- Genetic testing is under-offered and should be offered more frequently. - Genetic specialist involvement is associated with increased patient education, genetic testing uptake, and diagnostic yield - Time and access to genetic specialists may drive testing rate - Non-English language may be associated with decreased consultation rate
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Global approaches to postmortem genetic testing after sudden cardiac death in the young: A survey among healthcare professionals
Lieke M. van den Heuvel, Judy Do, … Jodie Ingles·Heart RhythmPeer-reviewed·Mar 27, 2021
- Multidimensional and Longitudinal Impact of a Genetic Diagnosis for Critically Ill Infants
Monica Hsiung Wojcik, Maya C. del Rosario, … Ingrid A. Holm·PEDIATRICSPeer-reviewed·Nov 8, 2024
- Genetic Counselor Utilization Across Non-Genetics Departments for Neurodevelopmental Disorders
Jordan Janae Cole, Julie S. Cohen, … Colleen A. Campbell·medRxiv·Jul 21, 2026
- Comparing Cardiac Genetic Testing Pathways: Impacts on Access, Informed Choice, and Decisional Satisfaction
Susan Christian, Talia C. Belcher, … Cathleen Huculak·Circulation Genomic and Precision MedicinePeer-reviewed·Sep 24, 2026
- Defining the Critical Components of Informed Consent for Genetic Testing: A Delphi Study
Kelly E. Ormond, Maia J. Borensztein, … Curtis R. Coughlin·Journal of Personalized MedicinePeer-reviewed·Dec 5, 2021
- Identifying barriers to genetic testing in subspecialty cardiac care
Sierra Pond, Genevie Echols, … Briana L. Sawyer·medRxiv·May 15, 2024